2d
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company with the goal of being ...
<?xml encoding="utf-8" ?> Treace Medical Concepts TMCI reported third-quarter financial results on Friday. The transcript ...
Explore the competitive landscape of the Podiatry Services Market through our analysis of leading companies, their market positioning, strategies, and recent developments. The assessment highlights ...
Generated revenue of $48.3 million in the third quarter 2026. Improved third quarter 2026 net loss by 23% to $(12.6) million, and Adjusted EBITDA by $2.9 million to $0.3 million when compared to the ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
When patients search online for bunion surgery, they often compare marketing campaigns, not evidence about experience.
Management attributed the Q3 revenue decline primarily to a shift in product mix toward lower-priced minimally invasive ...
Operator: Thank you for standing by, and welcome to Treace Medical Concepts third quarter 2026 Earnings Conference Call. At ...
Treace Medical Concepts, Inc. announced the successful completion of the first cases utilizing its Tailorplasty? MIS Tailor?s Bunion Correction System. The Tailorplasty? procedure extends Treace's ...
Treace Medical Concepts, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 48.25 million compared ...
トレース・メディカル・コンセプツの2026年第3四半期決算は、低価格な低侵襲製品への構成比シフト等により売上高が前年同期比4%減の4,830万ドルとなった一方、外科医の手術件数は2桁成長を記録した。営業費用は10%減少し、調整後EBITDAは30万ド ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results